Belarus to complete Sputnik V full-cycle production project by June 2022
MINSK, Nov. 12 (BelTA) – The Sputnik V vaccine produced as part of Belarus’s full-cycle production project will be available for use by June 2022, Belarusian Prime Minister Roman Golovchenko told reporters during his visit to the pharmaceutical company Belmedpreparaty on November 12, BelTA learned.
The company presented an investment project to launch a full cycle of pharmaceutical production of the Sputnik V vaccine in Belarus. Roman Golovchenko was accompanied by Deputy Prime Minister Igor Petrishenko and Minister of Health Dmitry Pinevich.
âThe project is progressing at a steady pace. We are now at an intermediate stage. The installation of world-class biotechnology equipment is nearing completion. The first validation batch will be rolled out here in December. 10% of the commercial lot will be stored and tested for stability. If all goes well, we will start registration procedures in Belarus and Russia. As per schedule, this vaccine is expected to be available for use in Belarus and other countries by early next summer. The total estimated production will exceed 10 million doses per year, of which 4 million doses are designed for Belarus, âsaid Roman Golovchenko.
According to him, the facility will be able to produce not only Sputnik V, but also other modern biological products if necessary. âThe vaccine will be the first pharmaceutical product to be manufactured in these premises, but thanks to versatile equipment, it will be possible to deploy a wide range of biological products in demand on the market. This installation is unique for Belarus in terms of pharmaceutical and biotechnological equipment, a real breakthrough â, he underlined.
Belmedpreparaty General Manager Sergei Belyayev recalled that the company is working on launching a complete production cycle of Sputnik V: from the biological production of the active substance to the production of a finished vaccine in the form of ampoules or of vials. The facility is expected to reach its nominal capacity in 2022-2023.